BIOMAT Database Logo BIOMAT Database Logo

Report on a cooperative study of nitrogen mustard (HN2) therapy of neoplastic disease. 1947

C P RHOADS

UI MeSH Term Description Entries
D008466 Mechlorethamine A biologic alkylating agent that exerts its cytotoxic effects by forming DNA ADDUCTS and DNA interstrand crosslinks, thereby inhibiting rapidly proliferating cells. The hydrochloride is an antineoplastic agent used to treat HODGKIN DISEASE and LYMPHOMA. Chlorethazine,Chlormethine,Mechlorethamine Oxide,Mustine,Nitrogen Mustard,Nitrogen Mustard N-Oxide,Bis(2-chloroethyl)methylamine,Caryolysine,Cloramin,Embichin,Mechlorethamine Hydrochloride,Mechlorethamine Hydrochloride N-Oxide,Mechlorethamine N-Oxide,Methylchlorethamine,Mitomen,Mustargen,NSC-10107,NSC-762,Nitrogranulogen,Nitromin,Hydrochloride N-Oxide, Mechlorethamine,Hydrochloride, Mechlorethamine,Mechlorethamine Hydrochloride N Oxide,Mechlorethamine N Oxide,N-Oxide, Mechlorethamine Hydrochloride,N-Oxide, Nitrogen Mustard,NSC 10107,NSC 762,NSC10107,NSC762,Nitrogen Mustard N Oxide
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D035843 Biomedical Research Research that involves the application of the natural sciences, especially biology and physiology, to medicine. Medical Research,Experimental Medicine,Investigational Medicine,Investigative Medicine,Research, Biomedical,Research, Medical,Medicine, Experimental,Medicine, Investigational,Medicine, Investigative

Related Publications

C P RHOADS
Experiments on the therapeutic index of nitrogen mustard (HN2).
January 1960, Acta - Unio Internationalis Contra Cancrum,
C P RHOADS
The Shwartzman phenomenon. I. Inhibitory action of nitrogen mustard (HN2).
August 1950, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
C P RHOADS
Early detection of injury after nitrogen mustard (HN2) therapy: the radioiron disappearance rate as a dosimeter.
April 1970, The International journal of applied radiation and isotopes,
C P RHOADS
Recovery of supralethally x-irradiated and nitrogen mustard (HN2)-treated amoebae.
January 1970, International journal of radiation biology and related studies in physics, chemistry, and medicine,
C P RHOADS
Effects of mechlorethamine (HN2, nitrogen mustard) on UV-induced carcinogenesis in hairless mouse skin.
February 1984, Journal of the National Cancer Institute,
C P RHOADS
Remissions of mycosis fungoides induced by nitrogen mustard (HN2). Topical treatment and hydration of tumours and plaques with HN2. Topical desensitization to HN2. A clinical and histopathological controlled study.
January 1978, Dermatologica,
C P RHOADS
Production of fever by influenzal viruses. V. Effect of nitrogen mustard (HN2).
July 1955, Bulletin of the Johns Hopkins Hospital,
C P RHOADS
ACTH and nitrogen mustard in the treatment of neoplastic disease.
October 1955, United States Armed Forces medical journal,
C P RHOADS
Experiences in the treatment of neoplastic disease with nitrogen mustard.
July 1947, The Yale journal of biology and medicine,
C P RHOADS
NITROGEN mustard drugs in neoplastic diseases.
January 1947, American professional pharmacist,
Copied contents to your clipboard!